BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17617522)

  • 1. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.
    Tropé C; Kaern J
    J Clin Oncol; 2007 Jul; 25(20):2909-20. PubMed ID: 17617522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.
    Paramasivam S; Tripcony L; Crandon A; Quinn M; Hammond I; Marsden D; Proietto A; Davy M; Carter J; Nicklin J; Perrin L; Obermair A
    J Clin Oncol; 2005 Sep; 23(25):5938-42. PubMed ID: 16087942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma].
    Trimbos JB; van der Burg ME
    Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
    Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic model for FIGO stage 1 epithelial ovarian cancer.
    Obermair A; Fuller A; Lopez-Varela E; van Gorp T; Vergote I; Eaton L; Fowler J; Quinn M; Hammond I; Marsden D; Proietto A; Carter J; Davy M; Tripcony L; Abu-Rustum N
    Gynecol Oncol; 2007 Mar; 104(3):607-11. PubMed ID: 17092548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the problem of inadequately staging early ovarian cancer.
    Timmers PJ; Zwinderman AH; Coens C; Vergote I; Trimbos JB
    Eur J Cancer; 2010 Mar; 46(5):880-4. PubMed ID: 20074933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].
    Lhommé C; Ray-Coquard I; Guastalla JP; Bataillard A; Thomas L; Bonnier P; Dargent D; Dohollou N; Ganem G; Lefranc JP; Misset JL; Rixe O; Tchiknavorian X; Tournigand C; Villet R; Bachelot T; Kerbrat P; Fervers B; Basuyau JP; Cohen-Solal-Le Nir C; Morice P; Duvillard P; Voog E; ; ; ; ; ;
    Bull Cancer; 2004; 91(7-8):609-20. PubMed ID: 15381451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ovarian germ cell tumors.
    Gershenson DM
    J Clin Oncol; 2007 Jul; 25(20):2938-43. PubMed ID: 17617525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of ovarian stromal cell tumors.
    Colombo N; Parma G; Zanagnolo V; Insinga A
    J Clin Oncol; 2007 Jul; 25(20):2944-51. PubMed ID: 17617526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary.
    Palenzuela G; Martin E; Meunier A; Beuzeboc P; Laurence V; Orbach D; Frappaz D
    Ann Surg; 2008 Nov; 248(5):836-41. PubMed ID: 18948812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.
    Möbus V; Wandt H; Frickhofen N; Bengala C; Champion K; Kimmig R; Ostermann H; Hinke A; Ledermann JA; ;
    J Clin Oncol; 2007 Sep; 25(27):4187-93. PubMed ID: 17698804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.